Cell Lysis Disruption Companies

Agilent Technologies acquires ProteinSimple: This expands Agilent's protein extraction and analysis capabilities, offering researchers comprehensive workflows for downstream cellular studies.

Sartorius enters into a strategic partnership with Bio-Techne: The collaboration focuses on developing and commercializing cell-based assays for drug discovery and development.

Danaher Corporation acquires Pall Corporation's biopharma business: This strengthens Danaher's presence in the life sciences filtration and purification market, with potential implications for cell lysis and disruption technologies.

Beckman Coulter introduces the Allegra X-f Microcentrifuge: This high-speed centrifuge offers advanced rotor designs and efficient cell disruption capabilities for various sample types.

Qiagen unveils the TissueLyser II and FastPrep 24 bead beating instruments: These new models provide improved speed, automation, and sample homogenization for both soft and hard tissues.

Eppendorf launches the PerfectDisruptor B300 Bead Mill: This innovative bead mill features programmable settings and temperature control for optimal cell disruption and sample preservation

• Thermo Fisher Scientific, Inc. (US)


• Merck KGAA (Germany)


• Bio-Rad Laboratories, Inc. (US)


• Danaher Corporation (US)


• Becton Dickinson & Company (US)


• Cell Signaling Technology, Inc. (US)


• Miltenyi Biotec (Germany)


• Hoffmann–La Roche Ltd. (Switzerland)


• Qiagen N.V. (Netherlands)


• Qsonica, LLC (US)